125 results about "Pancreatic enzymes" patented technology

A therapeutic agent for the treatment of toxemia, preeclampsia and eclampsia and the method for preparing the therapeutic agents is disclosed. The therapeutic agent is a stable pharmaceutical preparation containing, but not limited to, digestive / pancreatic enzymes. The therapeutic agent may be manufactured by a variety of encapsulation technologies. Delivery of the therapeutic agent may be made orally, through injection, by adherence of a medicated patch or other method. Further, a method of using of a biomarker, the presence of chymotrypsin in the maternal GI tract to determine the likelihood of developing preeclampsia, pregnancy induced hypertension, and eclampsia / toxemia is disclosed.

A stable preparation of digestive / pancreatic enzymes which can be readily formed into a dosage formulation is provided as a treatment of pancreatic insufficiency in persons having cystic fibrosis. The dosage formulation can be administered either by an oral preparation including, but not limited to, a microcapsule, mini-capsule, time released capsule, sprinkle or other methodology. A further object of this invention is to provide a stabilized preparation of a combination medicant which resists degradation by light, heat, humidity or association with commonly used excipients.

A method for treating a Parkinson's patient with digestive / pancreatic enzymes involves administering an effective amount of digestive / pancreatic enzymes to an individual having the disorder in order to improve a symptom of the disorder. In addition, a method is provided for determining whether an individual has, or may develop, Parkinson's disease or related dysautonomic disorders and for determining whether an individual will benefit from the administration of pancreatic / digestive enzymes to treat the dysautonomic disorder.

The invention provides a chicken bone protein zymolyte and a chicken essence substrate prepared by the chicken bone protein zymolyte, belonging to the technical field of poultry processing. The invention solves the problems of high cost for producing a chicken essence substrate, limited raw material sources, unavailable effective utilization generally by discarding leftovers, such as chicken bone, and the like, and the like in the prior art. In the invention, a novel chicken essence substrate is developed by adopting the cheap leftovers, namely chicken bone as a raw material and utilizing a biological enzymolysis technology and a hot reaction spice research technology; the chicken essence substrate is prepared by the following steps of: adopting the chicken bone zymolyte obtained after the chicken bone is subjected to double enzymolysis by pancreatic enzyme and Flavourzyme composite flavor protease as a main material, mixing the main material with hydrolyzed vegetable protein (HVP), a yeast extract, glucose, xylose, thiamine, chicken oil and propylene glycol according to a certain proportion; and carrying out Maillard reaction in a high-pressure reactor to prepare the chicken essence substrate with vivid chicken fragrance. The chicken essence substrate has vivid chicken fragrance, rich and strong chicken fragrance and long aftertaste.

A therapeutic agent for the treatment of the symptoms of addiction and the method for preparing the therapeutic agent is disclosed. The therapeutic agent is a stable pharmaceutical preparation containing, but not limited to, digestive / pancreatic enzymes. The therapeutic agent may be manufactured by a variety of encapsulation technologies. Delivery of the therapeutic agent may be made orally, through injection, by adherence of a medicated patch or other method. Further, a method of using of a biomarker, the presence of chymotrypsin in the gastrointestinal tract to determine the presence of symptoms of addiction, and the likelihood of relapsing into addiction is disclosed.

A therapeutic agent for the treatment of toxemia, preeclampsia and eclampsia and the method for preparing the therapeutic agents is disclosed. The therapeutic agent is a stable pharmaceutical preparation containing, but not limited to, digestive / pancreatic enzymes. The therapeutic agent may be manufactured by a variety of encapsulation technologies. Delivery of the therapeutic agent may be made orally, through injection, by adherence of a medicated patch or other method. Further, a method of using of a biomarker, the presence of chymotrypsin in the maternal GI tract to determine the likelihood of developing preeclampsia, pregnancy induced hypertension, and eclampsia / toxemia is disclosed.

Pigskin is processed to provide a bleached, expanded skin used in dog treat or chew products. The raw pigskin is dehaired and then daubed with an alkali mixture of an alkali liquid, alkali enzymes and lime, the mixture having a pH of greater than or equal to 12. The alkali mixture dissolves the colloidal protein. The alkali is removed by alternately rinsing the skin in water and agitating the skin with first ammonium chloride or ammonium sulfate, and then second with ammonium chloride or ammonium sulfate, and pancreatic enzymes. The skin is agitated with sodium carbonate and a degreaser to remove the fat. The skin is then washed with hydrogen peroxide, which bleaches and expands the skin. The skin is then formed into a dog product and dried.

The invention provides a culture apparatus used for temperature sensitive cells, a preparation method thereof and a cell cultureing method. The culture apparatus used for temperature sensitive cells comprises a polystyrene body; and the polystyrene body is grafted with a polystyrene-poly N-isopropylacrylamide block polymer. Compared with existing technologies, when the culture apparatus used for temperature sensitive cells is used for cell culturing, it is possible to obtain complete cultured cell layers and extracellular matrixes from deposition of the culture cell layers without damage by simple temperature variation, digestion by pancreatic enzyme or dissociation by chemical reagents is avoided, the death of cells is reduced, damages to the extracellular matrixes are lessened, and quality and activity of the cultured cells are improved.

A method for extracting a small molecule peptide from a fresh animal bone is provided. The technological process of the method comprises the following steps: cleaning and breaking a fresh cattle or sheep bone, autoclaving, adding a special bone enzyme to conduct enzymolysis, deodorizing, filtering, concentrating, spraying the power to dry, and packaging a finished product. The method is characterized in that the temperature is higher than 120 DEG C, the pressure is 0.15-0.16 MPa and the fresh cattle or sheep bone is cooked for 8 h in the step of autoclaving; in the step of enzymolysis, the temperature is reduced to 54-56 DEG C after raising the temperature and sterilizing, NaOH is added to regulate the pH to 7.0, then the 0.5% special bone enzyme comprising an incision enzyme, an excision enzyme, a flavor enzyme and a pancreatic enzyme is added to conduct enzymolysis for 6 h; in the step of deodorizing, activated carbon is used; in the step of filtering, a candle filter and then a barrel filter are used; in the step of concentrating, the concentration pressure is -0.4 MPa to -0.6 MPa, and the concentration temperature is between 75 DEG C to 80 DEG C. The method has the advantages that the protein in the animal bone is hydrolyzed through bio-enzymes into all water-soluble nutritional ingredients, a product is high in the content of the small molecule peptide and the solubility, is favorable for absorbing by a human body, and is suitable for extracting the small molecule peptide of various animal bones.

Compositions of the present invention, comprising the combination of enterically coated and uncoated pancreatic enzyme-containing beads are useful for treating or preventing pancreatitis pain, and optionally disorders associated with digestive enzyme deficiencies.

The present invention relates to the technical field of Traditional Chinese medicine, in particular to a traditional Chinese medicine composition and the use thereof. The traditional Chinese medicine composition comprises the following ingredients: honeysuckle, tangerine peel, stir-baked malt, honey, and hawthorn juice. The traditional Chinese medicine composition of the present invention has significant promotions on the gastric emptying rate, intestinal motility, gastric digestive enzyme (pepsin) activity and pancreatic enzyme (trypsin, chymotrypsin, amylase and lipase) activity of rats, exhibiting that the traditional Chinese medicine composition of the present invention has significant effects of clearing heat-fire and moistening the intestine.